Skip to main content
新芝生物 logo

新芝生物 — Investor Relations & Filings

Ticker · 920685 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 390 across all filing types
Latest filing 2024-05-16 Declaration of Voting R…
Country CN China
Listing Beijing Stock Exchange 920685

About 新芝生物

https://www.scientz.com/

Scientz Biotechnology specializes in the design and manufacture of high-performance life science instruments and laboratory equipment. The product range features ultrasonic cell disruptors, freeze dryers, gene guns, and high-pressure homogenizers, which are essential for sample preparation, cell lysis, and genetic engineering. The company also provides specialized solutions for tissue grinding, ultrasonic cleaning, and precise temperature control. These instruments serve a broad spectrum of applications in molecular biology, pharmaceutical research, environmental science, and agricultural technology. By integrating advanced ultrasonic and cryogenic technologies, Scientz supports research institutions and industrial laboratories in achieving accurate and reproducible results across various scientific disciplines.

Recent filings

Filing Released Lang Actions
北京炜衡（宁波）律师事务所关于宁波新芝生物科技股份有限公司2023年年度股东大会之法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 85% confidence The document is a legal opinion letter issued by an external law firm verifying the convening, attendance, procedures, and the detailed vote counts for each resolution at the company’s 2023 Annual General Meeting. It is not a financial report, presentation deck, or a mere announcement of a report’s publication, but it officially discloses the voting results—listing for each proposal the number of votes for, against, and abstentions. Under the taxonomy, this fits “Declaration of Voting Results & Voting Rights Announcements” (DVA).
2024-05-16 Chinese
2023年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a "2023 Annual General Meeting Resolution Announcement" from Ningbo New Century Biotechnology Co., Ltd. It details the convening and attendance of the 2023 Annual General Meeting (AGM), the voting results on various proposals including the 2023 Board Work Report, Supervisory Board Work Report, Independent Directors' Reports, 2023 Financial Statements, Annual Report, Dividend Distribution Plan, and other related matters. The document includes voting percentages and confirms the legality and validity of the meeting and resolutions. It does not contain the full annual report or financial statements themselves but rather the official announcement of the AGM resolutions and voting outcomes. The document length is about 4537 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-05-16 Chinese
投资者关系活动记录表
Call Transcript Classification · 95% confidence The document is titled as an "投资者关系活动记录表" which translates to "Investor Relations Activity Record". It details a performance explanation meeting (业绩说明会) held on May 13, 2024, discussing the company's 2023 annual report results and answering investor questions. The content includes detailed Q&A about the company's business, financial performance, R&D, market positioning, and future outlook. The document is 5337 characters long, which is sufficient to contain substantive content rather than just an announcement. The nature of the document is a transcript or record of an earnings explanation meeting, which aligns with a Call Transcript (CT) filing type, as it contains detailed discussion and Q&A on financial results and company strategy. It is not a full Annual Report (10-K) or Interim Report (IR) because it is a meeting record, not a formal report with financial statements. It is not a simple announcement or publication notice (RPA) because it contains detailed content. Therefore, the best classification is Call Transcript (CT).
2024-05-14 Chinese
控股股东增持股份结果公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding the results of a shareholding increase by a controlling shareholder. It details the shareholder's identity, the planned and actual share purchases, reasons for not meeting the planned increase, and compliance with trading regulations. There are no financial statements, earnings data, or management discussions typical of financial reports. The content focuses on shareholding changes by a major shareholder, which fits the definition of a Major Shareholding Notification (MRQ). The document length is short and it is not a report publication or certification. Therefore, the appropriate classification is MRQ.
2024-05-07 Chinese
2023年年度报告业绩说明会预告公告
AGM Information Classification · 95% confidence The document is a notice announcing a scheduled annual report earnings explanation meeting (业绩说明会) for the 2023 annual report of 宁波新芝生物科技股份有限公司. It references the 2023 annual report already published on April 22, 2024, and invites investors to participate in a webcast meeting on May 13, 2024. The document does not contain the annual report itself or detailed financial data, but rather announces the event to discuss the annual report. The document length is short (1166 characters) and it is clearly an announcement of a meeting related to the annual report, not the report itself. Therefore, it fits the category of AGM Information (AGM-R) as it is a presentation/meeting material related to the annual report, or possibly a Report Publication Announcement (RPA). However, since it is specifically about an annual report explanation meeting (说明会), which is a form of AGM or investor meeting presentation, the best fit is AGM Information (AGM-R).
2024-05-07 Chinese
投资者关系活动记录表
Investor Presentation Classification · 95% confidence The document is titled as an "投资者关系活动记录表" which translates to "Investor Relations Activity Record." It details an investor relations event held online on April 24, 2024, including participants, questions asked, and company responses. The content focuses on business performance review, product development, market outlook, and strategic plans. It is not a formal financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a regulatory filing or certification. It is also not a presentation or earnings release but a record of an investor relations meeting. Given the nature of the document as a record of an investor relations activity, it best fits the category of Investor Presentation (IP), which includes detailed presentations for investors focusing on financials, strategy, and market position. The document length is 3280 characters, which is consistent with a detailed summary rather than a full report. Therefore, the classification is Investor Presentation (IP) with high confidence.
2024-04-25 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.